Quinolinic Acid: An Endogenous Neurotoxin with Multiple Targets
Open accessThe DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
Abstract
Quinolinic acid (QUIN), a neuroactive metabolite of the kynurenine pathway, is normally presented in nanomolar concentrations in human brain and cerebrospinal fluid (CSF) and is often implicated in the pathogenesis of a variety of human neurological diseases. QUIN is an agonist of N-methyl-D-aspartate (NMDA) receptor, and it has a high in vivo potency as an excitotoxin. In fact, although QUIN has an uptake system, its neuronal degradation enzyme is rapidly saturated, and the rest of extracellular QUIN can continue stimulating the NMDA receptor. However, its toxicity cannot be fully explained by its activation of NMDA receptors it is likely that additional mechanisms may also be involved. In this review we describe some of the most relevant targets of QUIN neurotoxicity which involves presynaptic receptors, energetic dysfunction, oxidative stress, transcription factors, cytoskeletal disruption, behavior alterations, and cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, QUIN increases the release and blocks the reuptake of glutamate in astrocytes, thus increasing glutamatergic extracellular concentrations (132).”
From Chronic stress, neuroinflammation, and depression: an overview of pathophysiological mechanisms and emerging anti-inflammatories (2023) · cites this paper as [132]
In the citing paper
“Together, this pathway may trigger hippocampal and mPFC cellular damage and volume reductions (138,144,145).”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [145]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular diversity of glutamate receptors and implications for brain function
Nakanishi, S. (1992) · Science · doi:10.1126/science.1329206 · Cited by 2,543 · cited 1×
“Areas of the brain most sensitive to QUIN neurotoxicity are the hippocampus and striatum [32] in which the NMDA receptors are widely distributed [33].”
BackgroundReplication of the neurochemical characteristics of Huntington's disease by quinolinic acid
Beal, M. F., Kowall, N. W., Ellison, D. W., Mazurek, M. F., Swartz, K. J., & Martin, J. B. (1986) · Nature · doi:10.1038/321168a0 · Cited by 1,286
Quinolinic Acid: An Endogenous Metabolite That Produces Axon-Sparing Lesions in Rat Brain
Schwarcz, R., Whetsell, W. O., & Mangano, R. M. (1983) · Science · doi:10.1126/science.6849138 · Cited by 1,263
Cytokines and endothelial cell biology
Pober, J. S., & Cotran, R. S. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.427 · Cited by 1,242 · cited 1×
“Although TNF-α is not neurotoxic itself, this proinflammatory cytokine can contribute to neuronal damage through a variety of effects, such as stimulation of free radical formation, induction of cellular adhesion molecule expression, or potentiation of glutamatemediate neurotoxicity [123, 124].”
BackgroundNeuropharmacology of quinolinic and kynurenic acids.
Stone, T. W. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00441-7 · Cited by 948 · cited 3×
“Furthermore, 3-HAO activity may normally be restrained by factors such as the availability of Fe ions [8, 22, 23].”
BackgroundSchulze-Osthoff, K., Bakker, A. C., Vanhaesebroeck, B., Beyaert, R., Jacob, W. A., & Fiers, W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42768-8 · Cited by 939
Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS
Stone, T. W., & Perkins, M. N. (1981) · European Journal of Pharmacology · doi:10.1016/0014-2999(81)90587-2 · Cited by 751 · cited 2×
“In 1981, Stone and Perkins discovered that QUIN was a potent excitant of neurons in the CNS, by acting as an agonist at the N-methyl-D-aspartate (NMDA) sensitive population glutamate receptors [29], and Schwarcz and coworkers (1983) were the first who demonstrated that QUIN causes selective neuronal lesions, and they…”
BackgroundKynurenine Pathway Metabolites in Humans: Disease and Healthy States
Chen, Y., & Guillemin, G. J. (2009) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s2097 · Cited by 628 · cited 1×
“8 nmol/g wet weight; almost 2-fold than that found in the hippocampus (1 nmol/g wet weight) [16–18].”
BackgroundSteiner, J., Walter, M., Gos, T., Guillemin, G. J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-94 · Cited by 568
Guillemin, G. J., Smythe, G., Takikawa, O., & Brew, B. J. (2005) · Glia · doi:10.1002/glia.20090 · Cited by 497 · cited 3×
“As shown previously in cortical neurons, dopaminergic neurons do not produce QUIN but take it up from the microenvironment [15, 40].”
Background
Research works printed but not linked: 1
- Blanco-Ayala T Serratos-Alvarez I Orozco-Ibarra M Effect of some kynurenines under succinate deshidrogenase activity and ATP production: in vitro experimental and computational tools Neuroscience Meeting 2012 60.09 New Orleans, LA, USA Society for Neuroscience
Cited by
Items 301–400 of 426
Mahalakshmi, A. M., Paneyala, S., Ray, B., Essa, M. M., Dehhaghi, M., Heng, B., Guillemin, G. J., & Chidambaram, S. B. (2022) · International Journal of Tryptophan Research · doi:10.1177/11786469221083946 · Cited by 4
Fongsaran, C., Dineley, K. T., Paessler, S., & Cisneros, I. E. (2024) · Pathogens · doi:10.3390/pathogens13050397 · Cited by 3
An analytical review of biosensor-based chronic pain quantification in healthcare
Kannan, A., West, D. W. D., Kumbhare, D. A., Ting, W., Ali, M. Y., Kawsar, H. I., Singh, G., Shanthanna, H., Hapidou, E. G., & Howlader, M. M. R. (2025) · Healthcare Analytics · doi:10.1016/j.health.2025.100419 · Cited by 3
Ikram, H., Perveen, S., & Haleem, D. J. (2025) · Nutritional Neuroscience · doi:10.1080/1028415x.2025.2565703 · Cited by 5
“This dose-dependent effect aligns with findings that moderate to high TRP doses increase quinolinic acid, an NMDA receptor agonist that exacerbates excitotoxicity and impairs learning [36].”
Arthur, R., Shanker, U., Singh, M., Singh, T. G., & Kumar, P. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138449 · Cited by 3
Omer, I. I. A., Kubbara, E. A., Hajali, T. A., Alaagib, N. A., & Hamdan, H. Z. (2026) · Brain Sciences · doi:10.3390/brainsci16020218 · Cited by 4
“Both QUIN and Hcy act as NMDA receptor agonists, which may induce excitatory signals and cortical spreading associated with migraine attacks [68].”
Inflammation in treatment-resistant depression: From mechanisms to therapeutics
Wu, S., Gao, X., Zhou, Y., Lin, Z., Chen, C. H., Luo, J., Liu, X., Lin, L., 邵红伟, & Liu, S. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111953 · Cited by 3
Guo, H., Qin, X., Tang, Y., Wang, C., Luo, Q., Gao, H., & Gao, Q. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117051 · Cited by 4
Hyeon, S. J., Kim, S. C., Chu, J., Kim, Y., Kim, C., Park, U., Tufail, Z., Nguyen, P. T., Eom, A., Kim, S., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02789-z · Cited by 3
“13 – 16 However, the potential role of QA in modulating microglial function, particularly at the cellular and molecular levels, remains incompletely understood.”
InfluentialNakasujja, N., Musisi, S., Agren, H., Katabira, E. T., & Allebeck, P. (2024) · BJPsych Open · doi:10.1192/bjo.2024.771 · Cited by 4
Tobacco induces abnormal metabolism of tryptophan via the kynurenine pathway
Onmaz, M., Onmaz, D. E., Demirbaş, N., Kutlu, R., Ünlü, A., & HATIR, A. E. (2025) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0286 · Cited by 3
Calvo‐Ochoa, E., Vorhees, N. W., Lockett, T. P., DeWitt-Batt, S. L., Thomas, E. A., Gray, A. B., Miyasaka, N., Yoshihara, Y., & Byrd-Jacobs, C. A. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.2456-24.2025 · Cited by 3
Rivi, V., Rigillo, G., Alboni, S., Koene, J. M., Pani, L., Lukowiak, K. D., Tascedda, F., Blom, J. M. C., & Benatti, C. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114418 · Cited by 3
Ferreira, F. S., Júnior, O. V. R., dos Santos, T. M., Silveira, J. S., Deniz, B. F., Alves, V. S., Coutinho‐Silva, R., Savio, L. E. B., & Wyse, Â. T. D. S. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00656-1 · Cited by 3
“These results corroborate previous studies that demonstrate the pro-inflammatory profile of this metabolite (Lugo-Huitrón et al. 2013; Braidy and Grant 2017; Jamwal et al. 2017; Ferreira et al. 2020).”
ResultMoon, P. K., & Minhas, P. S. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13677 · Cited by 3
Ma, R., Zhang, H., Wang, W., Yu, C., Xiong, G., Li, Q., Wang, Y., Zhou, L., Zhang, Y., Li, M., et al. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1567064 · Cited by 3
Parasite-mediated alteration of behaviour and biomolecular dynamics in a mouse model
Leonardi, S. S., Png, C. W., Bo, A. S., Wong, P., Iyer, V. R., & Tan, K. S. W. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1574660 · Cited by 2
Park, Y., Song, Y., Koh, J. H., Lee, J. J., Kim, W., Park, S. H., & Kwok, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-24287-y · Cited by 2
“However, despite this potential counter-regulatory role, QA is also known to exert proinflammatory and neurotoxic effects 24 .”
DÜNDAR, A., & Yıldız, S. Ç. (2025) · International Journal of Retina and Vitreous · doi:10.1186/s40942-025-00757-3 · Cited by 2
“Previous studies have also emphasized that KYNA has neuro-protective effects and 3HK has neurotoxic effects, and that this balance is critical for retinal health [18, 25].”
Animal models of Huntington's disease. Pros and cons
Stepanova, P., Voutilainen, M. H., Eriksson, O., & Lindholm, D. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101149 · Cited by 3
Dell’Oste, V., Palego, L., Bordacchini, A., Rimoldi, B., Parrini, L., Pedrinelli, V., Giannaccini, G., Betti, L., & Carmassi, C. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1680907 · Cited by 3
“…selective cell survival is crucial and increased energy metabolism is required, or, as well, in the context of intense defence responses, when lymphocyte clonal differentiation as well as shortages/unavailability of active biomolecules occur, due to their engagement under strong distress (45, 54).”
InfluentialWilliams, M. E., Schutte, L., Asia, L. K., Wissing, M. P., & van Vuren, E. J. (2026) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10278-3 · Cited by 3
“Mechanistically, QUIN can drive excitotoxicity via N-methyl-D-aspartate (NMDA) receptor agonism, disrupting glutamatergic signalling and promoting synaptic injury (Lugo-Huitrón et al. 2013).”
Altered Cerebrospinal Fluid Tryptophan–Kynurenine Pathway Metabolism in Multiple System Atrophy
Nagao, R., Kawabata, K., Mizutani, Y., Shima, S., Ueda, A., Ito, M., Maeda, Y., Mouri, A., & Watanabe, H. (2026) · Movement Disorders · doi:10.1002/mds.70210 · Cited by 2
Tryptophan’s Journey Through Pregnancy: The Role of Serotonin
Gendrot, B., Vaillancourt, C., & Fouquet, G. (2026) · International Journal of Tryptophan Research · doi:10.1177/11786469261449491 · Cited by 2
Kynurenine pathway impact on immune evasion and inflammation in acute myeloid leukemia
Wawrzak-Pienkowska, K., Golonko, A., Ignatiuk, D., Swidnicka-Siergiejko, A. K., Pienkowski, T., & Kurek, K. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124474 · Cited by 2
Maldonado-García, J. L., García-Mena, L. H., Ferat-Peláez, E. A., Pérez‐Sánchez, G., Becerril‐Villanueva, E., Rojas-Mayorquín, A. E., Girón‐Pérez, M. I., Ortuño‐Sahagún, D., & Pavón, L. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1831349 · Cited by 2
Wang, Y., Anzivino, M. J., Zhang, Y., Bertram, E. H., Woznak, J., Klibanov, A. L., Dumont, E., Wintermark, M., & Lee, K. S. (2021) · Journal of neurosurgery · doi:10.3171/2021.7.jns21123 · Cited by 2
Environmental pollutants and brain cancers: where do we stand
Migliaccio, M., Williams, S. J., & Caracciolo, V. (2021) · Annals of Research in Oncology · doi:10.48286/aro.2021.30 · Cited by 3
Ikari, T., Furusawa, Y., Tabuchi, Y., Maruyama, Y., Hattori, A., Kitani, Y., Toyota, K., Nagami, A., Hirayama, J., Watanabe, K., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-35222-4 · Cited by 3
Coluccia, M., Secci, D., & Guglielmi, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823974-2.00024-3 · Cited by 6
Hull, B., Miller, K. M., Corban, C., Backer, G., Sheehan, S. M., Korstanje, R., & Sutphin, G. L. (2024) · Biomolecules · doi:10.3390/biom14050599 · Cited by 2
A salt from biologically active compounds pyridine-2,3-dicarboxylic (quinolinic) acid and cytosine
Ksiąźkiewicz, O. (2024) · Acta Crystallographica Section C Structural Chemistry · doi:10.1107/s2053229624009598 · Cited by 2
Detection of a Neurotoxin Quinolinic Acid at Ultra‐Trace Amount: SERS and DFT Study
Nayak, M., Patel, C. B., Prakash, O., Singh, A. K., & Singh, R. K. (2025) · Journal of Raman Spectroscopy · doi:10.1002/jrs.6847 · Cited by 2
Kuuskmäe, C., Mikheim, K., Mohammadrahimi, N., Kilk, K., Kaare, M., Jayaram, M., Ilnitski, G., Leidmaa, E., Philips, M., & Vasar, E. (2026) · Scientific Reports · doi:10.1038/s41598-026-35968-7 · Cited by 3
Boczonadi, V., King, M. S., Smith, A. C., Oláhová, M., Bánsági, B., Roos, A., Eyassu, F., Borchers, C. H., Ramesh, V., Lochmüller, H., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0506-1 · Cited by 2
APOE polymorphism is associated with changes in the kynurenine pathway
Farup, P. G., Rootwelt, H., & Hestad, K. (2023) · Genes · doi:10.3390/genes14101955 · Cited by 1
ROLE OF KYNURENINE PATHWAY METABOLITES IN DEPRESSION-A REVIEW
Soni, P., Singh, L., Singh, P. K., & Kumar, S. (2020) · Journal of Applied Pharmaceutical Sciences and Research · doi:10.31069/japsr.v3i3.1 · Cited by 1
Carvalho, M. D. S. D. N., de Moraes, R. R., & Filho, E. M. T. (2022) · Research Society and Development · doi:10.33448/rsd-v11i8.31319 · Cited by 2
“In addition, QUIN also stimulates greater glutamate release and inhibits its reuptake, which causes greater calcium influx and neurodegeneration (Lugo-Huitrón et al, 2013).”
BackgroundIliev, P., Ivanov, S., Lazarov, S., & Bocheva, G. (2025) · Pharmacia · doi:10.3897/pharmacia.72.e148033 · Cited by 2
“Vice versa, QA, which is primarily produced in the microglial cells, acts as a partial agonist to the NMDA receptors and exhibits neurotoxic properties (Guillemin et al. 2005a; Lugo-Huitrón et al. 2013).”
Ein‐Dor, T. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_29 · Cited by 1
Al‐Hakeim, H. K., Al-Issa, A. A. R., Chen, C., & Maes, M. H. J. (2025) · Acta Neuropsychiatrica · doi:10.1017/neu.2025.5 · Cited by 1
Lunge, A. R., Östman, L., Tansey, R. C., Roche, D. J. O., Paul, E. R., Capusan, A. J., Heilig, M. A., & Mayo, L. M. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06953-1 · Cited by 1
“For instance, 3-HK and QUIN have been shown to exhibit neurotoxic properties, includ - ing excitotoxicity (Guidetti and Schwarcz 1999; Lugo-Huitrón et al. 2013 ; Schwarcz et al. 1983 ; Schwarcz and Köhler 1983; Stone and Perkins 1981), and elevations in these metabolites have been observed in…”
Yuan, J., Dan, A., Xie, P., Chen, J., Lin, Z., & Cai, Z. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.08.025 · Cited by 1
Monge, K. M., Najarro, K. M., McMahan, R. H., Kovacs, E. J., & Idrovo, J. (2025) · The FASEB Journal · doi:10.1096/fj.202502890rrr · Cited by 2
“This metabolite acts as an N- methyl- D-aspartate receptor agonist, generating excitotoxicity and oxidative stress [53].”
Hillman, C., Petracco, G., Fontana, B. D., Scaia, M. F., Vecchia, E. D., Wetton, J. H., Norton, W., Parker, M. O., & Reichmann, F. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107251 · Cited by 1
Kumari, J., Das, S., Ranjan, S., & Singh, S. (2026) · 3 Biotech · doi:10.1007/s13205-026-04885-x · Cited by 1
“…exists because researchers have not conducted clinical trials that study how targeted dietary prebiotic interventions affect tryptophan degradation pathways in humans by shifting the balance between neurotoxic kynurenine production and neuroprotective indole synthesis (Lugo-Huitrón et al. 2013).”
Kim, O. Y., & Song, J. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119527 · Cited by 1
Saadé, M. C., Saliba, A., Clark, A. J., Debnath, S., Zhang, S., Ragi, N., Etzrodt, V., Al-Humaidi, R., Vu, K. Q., Tao, Y., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec9689 · Cited by 1
Mesripour, A., Purhasani, A., & Hajhashemi, V. (2019) · The Thai Journal of Pharmaceutical Sciences · doi:10.56808/3027-7922.2356 · Cited by 4
Post-Acute COVID-19 Sequelae – ‘COVID Long Hauler’
Richards, G. A., Wentzel, A., Miller, R. E., van Zyl-Smit, R. N., & Telluraves Aerospace, C. T. (2021) · Wits Journal of Clinical Medicine · doi:10.18772/26180197.2021.v3n2a4 · Cited by 1
Kelly, B., Diez‐Cecilia, E., Pan, L., Sweeting, B., Villar, L., Kreft, A., Gupta, M., Johnson, S. L., & Weaver, D. F. (2022) · Canadian Journal of Chemistry · doi:10.1139/cjc-2021-0324 · Cited by 2
Cerebrospinal Fluid Biomarkers in Huntington’s Disease
Pio, F., & Leavitt, B. R. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_2 · Cited by 1
Basson, C., Serem, J. C., Bipath, P., & Hlophe, Y. N. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150851 · Cited by 1
Mercuriali, G., Lodde, L., Paribello, P., Sapienza, J., Corona, A., Ave, C., Pacini, D., Nocera, D., Corrias, C., Kacemi, S. E., et al. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1451678 · Cited by 3
Oxidative stress in Huntington's disease knock-in striatal cells
Ribeiro, M. J. D. C. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 2
Study towards the quantitative definition of the kynurenine pathway
Murray, T. B. J. (2017) · ERA · Cited by 1
Lamine-Ajili, A. (2018) · theses.fr (ABES) · doi:10.70675/f8bcaa8cza888z4b1dz806czbabde74903db · Cited by 1
“métabolisme du tryptophane (Trp) peut aussi contribuer au déclenchement de ce processus, et ce, par l’hyperstimulation des récepteurs NMDA induite par l’acide quinoléique, un métabolite de la voie de la kinurénine (métabolite de Trp ; Lugo-Huitron et al., 2013).”
Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Algon, A. A. A., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · medRxiv · doi:10.1101/2022.02.01.22270268 · Cited by 3
Experimental Modelling of Spinal Anaesthesia in Rats
Dobos, I. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2659
Entzündungsbedingte Depression und assoziierte Risikofaktoren bei ambulanten Patienten
Peter, H. L., & Hellhammer, D. H. (2016) · Verhaltenstherapie · doi:10.1159/000452785
“Die Chinolinsäure hat neurotoxische und neurodegenerative Effekte und kann somit über eine Überstimulation des NMDA-Rezeptors die Neuroplastizität des ZNS beeinträchtigen [Lugo-Huitron et al., 2013].”
BackgroundGut Microbial Metabolism in Health and Disease
Jia, W. P., & Rajani, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802928-2.00038-2
The role of resting mast cells in the survival of myenteric neurons
Knoch, J. (2019) · MacSphere (McMaster University) · doi:10.71548/12860
Development of an acute excitotoxic model of Huntington's disease in sheep
O’Connell, A. (2020) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Marques, L. B. (2022) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.46.2022.tde-06092022-130610
622 Childhood-onset SLE Outcomes in the CARRA Lupus Registry
Son, M. B. F., Knight, A., Schanberg, L. E., von Scheven, E., Amin, S., & Hersh, A. O. (2022) · Lupus Science & Medicine · doi:10.1136/lupus-2022-lupus21century.43
Gusdon, A. M., Savarraj, J. P. J., Feng, D., STARKMAN, A. E., Li, G., Bodanapally, U. K., Zimmerman, W. D., Ryan, A. S., Choi, H. A., & Badjatia, N. (2023) · Research Square · doi:10.21203/rs.3.rs-3600439/v1
“Although we measured circulating quinolinate in plasma, quinolinate is also well known to have neurotoxic effects in the CNS as it is an agonist of the N-methyl-D-aspartate (NMDA) receptor and acts as an excitotoxin 44 .”
BackgroundPseudoexfoliation Syndrome Post COVID Vaccination
Russell-Jones, G. J. (2024) · Journal of Medical - Clinical Research & Reviews · doi:10.33425/2639-944x.1374
Ein‐Dor, T. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_29-1
Naseer, Z., Khan, M., Manalai, N., Osmani, G. P., Foroobar, A., Harrison, P., Donna, C., Scercy, C., Yanoff, B., & Manalai, P. (2024) · International Journal of Medicine Sciences · doi:10.33545/26648881.2024.v6.i2a.50
Activation of NMDAR/Ca2+/CaKMII/ROS pathway by Brucella induced neuronal cell apoptosis
Liu, M., Yu, H., Wang, Y., Shi, S., Liu, H., Cao, X., Sun, L., Yang, H., & Zhang, Z. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578620
Whole body vibration alleviates depressive symptoms through its anti-inflammatory effects
Duan, Y., Xiong, L., Li, J., Jiang, J., Chen, Y., Zhou, J., & Li, T. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111690
Bavato, F., Steuer, A. E., Jacobsen, A. M., Zacher, A., Zimmermann, J., Cole, D. M., Opitz, A., Baumgartner, M. R., Stock, A., Beste, C., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04069-4
Takase, H., Fujisawa, T., Hayashi, R., Makinoshima, H., Suzuki, Y., Soga, T., & Fujii, S. (2025) · Pathobiology · doi:10.1159/000548128
“It is neurotoxic and has been implicated in neurodegenerative diseases [33].”
Marenco, A., Miyazaki, Y., Santos, M. C., Ikeda, T., Marutani, E., Lichtenegger, P., Łukowski, R., Sinow, C. O., Bloch, D. B., & Ichinose, F. (2025) · Nitric Oxide · doi:10.1016/j.niox.2025.10.007
Magnesium Deficiency Accelerates Aging and Shortens HealthspanPreprint
Chambers, P. W. (2025) · Qeios · doi:10.32388/57ll9y
Magnesium Deficiency Accelerates Aging and Shortens HealthspanPreprint
Chambers, P. W. (2025) · Qeios · doi:10.32388/57ll9y.2
Wang, S., Zhao, Y. P., Pan, J., Zhang, D., Wang, A., & Ma, K. (2025) · Psychopharmacology · doi:10.1007/s00213-025-06978-6 · Cited by 1
“Excess QUIN accumulation activates N-methyl-D-aspartate (NMDA) receptors (Lugo-Huitrón et al. 2013), which leads to cytotoxic calcium overload and neuronal damage, further exacerbating depression (González-Cota et al. 2024).”
Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Algon, A. A. A., Hakeim, H. K. A., & Maes, M. H. J. (2022) · Figshare · doi:10.6084/m9.figshare.20329527
Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Algon, A. A. A., Hakeim, H. K. A., & Maes, M. H. J. (2022) · Figshare · doi:10.6084/m9.figshare.20329524
Connell, E. (2025) · UEA Digital Repository (University of East Anglia) · Cited by 1
Todorović, N., Đorđević, N. O., Stanisavljević, A., Bajić, S. S., & Perić, I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18010140 · Cited by 1
Evidence Based on Sleep Disorder Exacerbating Postoperative Pain via Kynureninase
Huang, N., Chen, Y., Yang, X., Tao, C., Zhang, Y., Yang, Y., Shu, B., Duan, G., & Chen, Y. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s565401
“As shown in Figure 10D, CBA treatment significantly increased the mechanical pain thresholds on post SNI days 7, 10, and 14.”
Tang, S.-J., Chen, Z.-Y., Song, Y.-F., Gu, Y., You, Y., & Zhou, D.-H. (2026) · Acta Tropica · doi:10.1016/j.actatropica.2026.108012
Sadek, M. (2023) · TSpace (University of Toronto)
Varga, N., Kis-György, R., Ajkay-Donáth, L., Tapody, Z. I., Vágvölgyi-Sümegi, E., Körtési, T., & Nagy-Grócz, G. (2026) · Biomolecules · doi:10.3390/biom16030440 · Cited by 1
“In contrast, alternative branches of the pathway yield metabolites such as 3-hydroxykynurenine (3-HK) and quinolinic acid (QUIN), which are associated with oxidative stress, mitochondrial dysfunction, and excitotoxicity [93–95].”
Mendez, P. A. A., Ordóñez, G., Meza‐Sosa, K. F., Ayala, T. B., Ortega, D. R., de la Cruz, G. P., González‐Esquivel, D. F., Corona, T., Rivera, J. F., Rivas, V., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19030513
Self-citationNasini, S., Pearl‐Dowler, L., López-Canul, M., Posa, L., Bertazzo, A., Gobbi, G., & Comai, S. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00850-w
Study of the involvement of brain tryptophan metabolism in obesity-induced memory deficits
Mezo‐González, C. E. (2022) · theses.fr (ABES) · doi:10.70675/d788c1bfz3965z4981za000z9c3f9f464001
Voie des kynurénines : une nouvelle cible thérapeutique dans l'hypertension artérielle pulmonaire ?
Penalva-Mousset, L. (2023) · theses.fr (ABES) · doi:10.70675/fde41f80z84afz41a4z8525zc30ff05491ad
García‐Juárez, M., Álvarez-Salas, B. E., Ruiz-Higareda, A. F., Marino-Martínez, I. A., & Pérez‐Maya, A. A. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1805884
Toxic metabolites of aromatic amino acids in autism spectrum disorders
Larionov, G., Aleksandrenkova, A. A., Generalov, V. O., Klyushnik, T., Obodzinskaya, I. E., Mamedov, L. A., & Morozov, S. (2026) · Molekulyarnaya Meditsina (Molecular medicine) · doi:10.29296/24999490-2026-02-02
Breit, S. (2026) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20260006
Importance of the inflammasome in gut-brain axis: from pathological driver to therapeutic target
Sarkar, S., Roy, S., & Choudhury, L. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02230-5
Pathological Remuneration of Oxidative Stress in Limiting Gut-Brain Axis
Kumar, R., Kashyap, A., & Naqvi, S. (2026) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-3-032-19837-2_5
Nagamine, T. (2026) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.120485
Neuroinflammation and treatment resistance in major depressive disorder
Miyata, S., Ishino, Y., & Shimizu, S. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1838472
Metadata
- Authors
- Lugo-Huitrón, R., Ugalde Muñiz, P., Pineda, B., Pedraza-Chaverrí, J., Ríos, C., & Pérez-de la Cruz, V.
- Affiliations
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Departamento de Neuroquímica, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Laboratorio de Neuroinmunología, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Insurgentes Sur 3877, S.S.A., 14269 México, DF, Mexico
- Departamento de Biología, Facultad de Química, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico
- Venue
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-14
- ISSN
- 1942-0994 (ISSN-L)
- 1942-0900
- PMC
- PMC3780648
- OpenAlex
- W1991576487
- Cited by
- 394
- References
- 146
- Citations by year
- 2026: 44 · 2025: 48 · 2024: 50 · 2023: 41 · 2022: 54 · 2021: 42 · 2020: 23 · 2019: 17 · 2018: 16 · 2017: 23 · 2016: 21 · 2015: 11 · 2014: 4
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Oxidative Medicine and Cellular Longevity (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Consejo Nacional de Ciencia y Tecnología (183867)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Keywords
- quinolinic acid, kynurenine pathway, neurotoxicity, excitotoxicity, presynaptic receptors, oxidative stress, transcription factors, cytoskeleton disruption, behavioral alterations, neuronal cell death, neurological disorders
- MeSH terms
- Animals, Energy Metabolism, Humans, Inflammation, Neurotoxins, Quinolinic Acid, Oxidative Stress, Neurodegenerative Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.